Share

Addictions Edited: the monthly take-home

The SSA podcast


Latest episode

  • 23. The SSA Annual Conference 2023

    14:56
    In this episode, Merve Mollaahmetoglu, Ben Scher, Zoe Swithenbank and Rob Calder talk live from the poster room (with mocktails) about their thoughts on day 1 of the SSA Annual Conference in 2023. They cover research into substance use among refugees, heroin assisted treatment, gambling research and ADHD and addiction.Apologies for a few sound quality issues in this episode.The opinions expressed in this podcast reflect the views of the presenters and interviewees and do not necessarily represent the opinions or official positions of the SSA.The SSA does not endorse or guarantee the accuracy of the information in external sources or links and accepts no responsibility or liability for any consequences arising from the use of such information.

More episodes

View all episodes

  • 22. Refugees, immigrant populations and substance use with Ebtesam Saleh

    34:57
    In this episode, Rob Calder talks to the SSA's Fred Yates Prize winner Ebtesam Saleh. They discuss her work researching substance use among refugees and immigrant populations as well as her career going from a pharmacist in Yemen to becoming an award-winning researcher. This interview was conducted in September 2023 ahead of Ebtesam's Fred Yates Prize presentation and at the SSA's Annual Conference in Newcastle on 9 and 10 November 2023."Migrants lost their safe zone at the beginning. Completely. In terms of their land, their own families and loved ones. So they are struggling to start a new life but at the same time are living in a parallel world in their painful memories."The opinions expressed in this podcast reflect the views of the author(s) and do not necessarily represent the opinions or official positions of the SSA.The SSA does not endorse or guarantee the accuracy of the information in external sources or links and accepts no responsibility or liability for any consequences arising from the use of such information.
  • 21. ADHD and addiction with Wim van den Brink

    32:14
    Professor Wim van den Brink will be giving the Society Lecture at the SSA's 2023 Annual Conference. In this special episode of the Addictions Edited podcast, he talks to Rob Calder about attention deficit hyperactivity disorder (ADHD) and addiction.“If we want to prevent substance use disorders in patients with ADHD, we have to start early.”In an exclusive interview for the Addictions Edited podcast, Wim says that he hopes to use his talk at the SSA conference to deliver a few key messages: firstly, that ADHD is very common in patients with addiction – perhaps one in four will have adult ADHD; secondly, that the overlap or comorbidity could be attributed to a number of things – from neurobiological and psychological factors, to genetics and the environment; and thirdly, that establishing the respective weight of these contributing factors is important for prevention and treatment – for example, in determining whether pharmacological treatments and neuromodulation could offer more promise than, say, psychotherapies.The opinions expressed in this post reflect the views of the author and do not necessarily represent the opinions or official positions of the SSA or the author’s academic institution.The SSA does not endorse or guarantee the accuracy of the information in external sources or links and accepts no responsibility or liability for any consequences arising from the use of such information.
  • 20. Prescribing and research consent for people who use benzodiazepines with Dr Karen Berry

    22:52
    In this podcast Rob Calder talks to Dr Karen Berry about the latest research in treatment for benzodiazepine use. They discuss the recent rise of illicit and prescribed benzodiazepines in recent years; the difference between prescribed and street drugs, and how drugs prescribed in the US are making their way onto illicit markets. “They've become a rising issue both as illicit benzos like etizolam...And then also people are using prescribed diazepam, but it's not prescribed to them. So they're able to get hold of proper diazepam but on the street.”Karen talks about her latest research project looking at prescribing regimes for people who want to address benzodiazepine use. She discusses why the team recruited people who use both benzodiazepines and opiates and the implications of their research for drug overdose deaths. Karen also talks about some of the issues raised by the project about gaining consent from participants and how that consent can change throughout an intervention and across different appointments and research team members. Dr Karen Berry is a research fellow at the University of Stirling employed by the Salvation Army Centre for Addiction and Substance Research.The opinions expressed in this podcast reflect the views of the guest(s) and do not necessarily represent the opinions or official positions of the SSA.The SSA does not endorse or guarantee the accuracy of the information in external sources or links and accepts no responsibility or liability for any consequences arising from the use of such information.
  • 19. Drug consumption rooms, core outcome sets and more with Gillian Shorter

    38:01
    Dr Gillian Shorter talks to podcast host Rob Calder about her research into drug consumption rooms, including how they work, why she doesn’t believe they are controversial interventions, and what the evidence base suggests about their effectiveness.“The big thing that always comes up though is ‘why are there no randomised controlled trials?’ It comes up every time and it's a very simple answer. We know these places save lives. We have an evidence base across multiple countries to show that it does. So, it's not ethical to randomise one area to have a drug consumption room and one not to.”She also explains the ethos behind her decision to research brief alcohol interventions and safer consumption facilities – two seemingly disparate types of substance use intervention – as well as her experience developing core outcome sets and her role with the Drugs and Alcohol Research Network (DARN). Papers mentioned in the podcast include the following:The effect of question order on outcomes in the orbital core outcome set for alcohol brief interventions among online help-seekers (QOBCOS): Findings from a randomised factorial trial. By Marcus Bendtsen and colleagues. Published in Digital Health (2023).Overdose prevention centres in the UK. By Adam Holland and colleagues. Published in The Lancet (2022).The United Kingdom's first unsanctioned overdose prevention site; A proof-of-concept evaluation. By Gillian Shorter and colleagues. Published in the International Journal of Drug Policy (2022).Prioritizing variables for evaluating the efficacy and effectiveness of brief interventions for reducing alcohol consumption: A Latin American perspective. By Marcela Tiburcio and colleagues. Published in the Journal of Studies on Alcohol and Drugs (2022).The “Outcome Reporting in Brief Intervention Trials: Alcohol” (ORBITAL) core outcome set: International consensus on outcomes to measure in efficacy and effectiveness trials of alcohol brief interventions. By Gillian Shorter and colleagues. Published in the Journal of Studies on Alcohol and Drugs (2021).Prioritization of outcomes in efficacy and effectiveness of alcohol brief intervention trials: International multi-stakeholder e-Delphi consensus study to inform a core outcome set. By Gillian Shorter and colleagues. Published in the Journal of Studies on Alcohol and Drugs (2019).Gillian Shorter’s work on core outcome sets for alcohol brief interventions (ORBITAL project) was funded by Alcohol Change/Alcohol Research UK (Research Innovation Grant Number: R2016/04) and her work on drug consumption rooms is supported by a grant from National Institutes of Health Research (NIHR204582: co-PI Professor Alex Stevens and Dr Gillian Shorter).~The opinions expressed in this podcast reflect the views of the author and do not necessarily represent the opinions or official positions of the SSA or the author’s academic institution.The SSA does not endorse or guarantee the accuracy of the information in external sources or links and accepts no responsibility or liability for any consequences arising from the use of such information.~
  • 18. Methadone, bupernorphine and COVID-19, with Nicky Kalk and Caroline Copeland

    42:11
    Dr Nicky Kalk and Dr Caroline Copeland talk about their research into methadone- and buprenorphine-related deaths during the COVID-19 pandemic. Nicky and Caroline talk me through the number of deaths they would expect to see in an average year and the differences between that and what happened during COVID-19-related lockdowns. Nicky tells us how the UK has influenced the US response to Hurricane Katrina whereby people were given larger amounts of opioid agonist medication than they were used to.“Instead of most people in early treatment being directly supervised consumption….the majority of people were converted to 2 weeks' worth of take-home supply.” Caroline and Nicky then talk about possible explanations for the overdose rates found among people not in treatment, indicating the protective impact that treatment can have for people. They also talk about how their study challenged their thinking about the impact of diversion on the risk of overdose. Finally, they talk about the overall impact that the COVID-19 pandemic had on people seeking and accessing treatment.“There are things that make us sustain a behaviour and things that make us think that it’s time to make a change. And I suppose something as catastrophic as a lock-down with all the potential impacts that that might have on support or access to one's drug of choice, maybe changed the equation for people.”The opinions expressed in this podcast reflect the views of the author and do not necessarily represent the opinions or official positions of the SSA or the author’s academic institution.The SSA does not endorse or guarantee the accuracy of the information in external sources or links and accepts no responsibility or liability for any consequences arising from the use of such information.
  • 17. Maike Klein on experiences of relapse

    39:25
    This podcast is for anyone who wants to understand the experience of and feelings associated with relapse.Dr Maike Klein talks about her qualitative research into relapse, and about how different people conceptualise and perceive relapse. She talks about how, for some, it is a process rather than an event, whereas for others it is a shocking and immediate experience. There are also elements of self-actualisation and learning that can follow a relapse - as well as the real fear that relapse can cause.Maike talks about the feelings of powerlessness that can accompany relapse as well as the importance that some people place on gaining trust in themselves. Looking further into the language of relapse, Maike explores how relapse is sometimes seen as a location by some people and the implications this has for working with substance use.Maike also spoke to people who work in addiction treatment services about their experiences working with people who relapse and of second-hand trauma.“How does it feel like for a therapist to witness their client’s relapse and does that impact the way that they approach their therapeutic work?”“It feels almost like torture in their minds of having that internal fragmentation that’s almost more difficult than the relapse experience itself”. The opinions expressed in this podcast reflect the views of the author(s) and do not necessarily represent the opinions or official positions of the SSA.The SSA does not endorse or guarantee the accuracy of the information in external sources or links and accepts no responsibility or liability for any consequences arising from the use of such information.